torsdag den 14. januar 2010

Hodgkin's Lymphoma

Staging
Prognosis
Treatment

Bleomycin pulmonary toxicity in HL. On PFT, toxicity is seen with decreased TLC and VC. Monitoring is done with monthly DLco and treatment is discontinued if the DLco falls below 30-35% of pretreatment values.

Ingen kommentarer:

Send en kommentar